MACROPHAGE ACTIVATION SYNDROME
Clinical trials for MACROPHAGE ACTIVATION SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MACROPHAGE ACTIVATION SYNDROME trials appear
Sign up with your email to follow new studies for MACROPHAGE ACTIVATION SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a common arthritis drug tame deadly dengue fever?
Disease control OngoingThis study is testing if a drug called anakinra, which calms the immune system, can help people hospitalized with severe dengue fever. Dengue can sometimes cause a dangerous overreaction of the body's own defenses, called a 'cytokine storm.' Researchers will give 160 patients in …
Matched conditions: MACROPHAGE ACTIVATION SYNDROME
Phase: PHASE2 • Sponsor: Oxford University Clinical Research Unit, Vietnam • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Scientists dig through old records to make new cancer treatments safer
Knowledge-focused OngoingThis study aims to learn from the past to make future cancer treatments safer. Researchers are reviewing the medical records of 500 children and adults who received immunotherapies, like CAR T-cell therapy, to understand their side effects. The goal is to identify patterns and ri…
Matched conditions: MACROPHAGE ACTIVATION SYNDROME
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC